American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on Inpatient Glycemic Control
Open accessThe DOI matches its Crossref record; 166 of the 171 references it cites were found in a registry or an index.
Abstract
Does inpatient management of hyperglycemia represent a safety concern? 5. What systems need to be in place to achieve these recommendations?6.Is treatment of inpatient hyperglycemia cost-effective?7. What are the optimal strategies for transition to outpatient care? 8. What are areas for future research? QUESTION 1: DOES IMPROVING GLYCEMIC CONTROL IMPROVE CLINICAL OUTCOMES FOR INPATIENTS WITHHYPERGLYCEMIA? -Hyperglycemia in hospitalized patients, irrespective of its cause, is unequivocally associated with adverse outcomes (5,6,18 -25).Hyperglycemia occurs in patients with known or undiagnosed diabetes, or it occurs during acute illness in those with previously normal glucose tolerance (termed "stress hyperglycemia") (8,26).Intervention directed at reducing blood glucose (BG) levels has resulted in improved outcomes in some, but not all, studies (5,18 -25).Several recent clinical trials in critically ill patients have reported no reduction in mortality from intensive treatment targeting near-euglycemia versus conventional management targeting BG Ͻ180 mg/dl (Ͻ10.0 mmol/l).Of considerable concern are reports of harm, with higher rates of severe hypoglycemia and even increased mortality (14) resulting from intensive glycemic control (12)(13)(14)16,27,28).This variability in results may be attributable to several factors, including differences in intravenous (IV) insulin treatment protocols and their implementation, glycemic targets, patient populations, methods for glucose monitoring, and insulin adjustment (12,29).The following section focuses primarily on results of recent studies with an RCT design that investigated patient outcomes with protocols targeting nearnormalization of BG levels.Readers are referred to a previous ACE position statement (9), an ACE/ADA consensus statement (11), and a technical review (8) for details related to earlier studies supporting inpatient glycemic management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Those without preexisting DM or stress hyperglycemia have a higher incidence of more postheart surgery complications.91,100–103”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [103]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredIn the citing paper
“Glucose targets >180 mg/dL or <110 mg/dL are no longer recommended in ICU patients.”
From A comparison study of continuous insulin infusion protocols in the medical intensive care unit: Computer-guided vs. Standard column-based algorithms (2010) · cites this paper as [25]
In the citing paper
“and the BG targets used in this study were lower than glycemic targets recently recommended by the AACE and ADA inpatient glycemic control task force.25”
From A comparison study of continuous insulin infusion protocols in the medical intensive care unit: Computer-guided vs. Standard column-based algorithms (2010) · cites this paper as [25]
In the citing paper
“Many guidelines that apply to hospitalized adults with hyperglycemia can probably be extrapolated to older adults130, 131.”
From Diabetes in Older Adults: A Consensus Report (2012) · cites this paper as [130]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Standards of Medical Care in Diabetes
Power, D. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,673
Intensive versus Conventional Glucose Control in Critically Ill Patients
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810625 · Cited by 5,119
Intensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639 · cited 4×
“Nevertheless, recent attempts to achieve tight glycemic control either have not reduced or have actually increased mortality in multicenter trials and clearly led to higher rates of hypoglycemia (13,14,16).”
BackgroundInfluentialIntensive insulin therapy and pentastarch resuscitation in severe sepsis
Brunkhorst, F. M., Engel, C., Bloos, F., Meier-Hellmann, A., Ragaller, M., Weiler, N., Moerer, O., Gruendling, M., Oppert, M., Grond, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa070716 · Cited by 2,921 · cited 5×
“The higher rates of severe hypoglycemia associated with intensive insulin therapy (12–14,16,27,28) raise the possibility that serious adverse events in the subgroup of patients experiencing hypoglycemia offset, at least in part, any benefit derived from strict glycemic control in the much larger subgroup of patients w…”
BackgroundInfluentialHyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes
Umpierrez, G. E., Isaacs, S. D., Bazargan, N., You, X., Thaler, L. M., & Kitabchi, A. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8341 · Cited by 2,195
Self-citationCapes, S. E., Hunt, D., Malmberg, K., & Gerstein, H. C. (2000) · The Lancet · doi:10.1016/s0140-6736(99)08415-9 · Cited by 2,187
Standards of Medical Care in Diabetes—2009
American Diabetes Association (2009) · Diabetes Care · doi:10.2337/dc09-s013 · Cited by 2,167
Bates, D. W. (1998) · JAMA · doi:10.1001/jama.280.15.1311 · Cited by 2,107
The Incidence and Severity of Adverse Events Affecting Patients after Discharge from the Hospital
Forster, A. J., Murff, H. J., Peterson, J. F., Gandhi, T. K., & Bates, D. W. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-3-200302040-00007 · Cited by 1,886 · cited 1×
“Medication errors and adverse drug events have been linked to poor communication of instructions to the patient at the time of discharge (156,157).”
Background
Research works printed but not linked: 5
- 28. Devos P, Preiser JC, Me ´lot C, et al. Im- pact of tight glucose control by intensive insulin therapy on ICU mortality and the rate of hypoglycaemia: final results of the GluControl study (Abstract). Intensive Care Med 2007;33:S189
- 87. Rodbard HW, Blonde L, Braithwaite SS, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract 2007; 13(Suppl. 1):1-68
- 93. DiNardo M, Donihi AC, DeVita M, et al. A nurse directed protocol for recogni- tion and treatment of hypoglycemia in hospitalized patients. Pract Diabetol 2005;22:37-40
- 97. Donihi AC, Rea RS, Mihalko MA, et al. Comparison of different methods of transitioning MICU patients from intra- venous to subcutaneous insulin (Ab- stract). Diabetes 2007;57:A542
- 117. Reider J, Lin H, Dinardo M, et al. Efficacy of a guideline for treatment of corticoste- roid related hyperglycemia in the hospi- tal (Abstract). Diabetes 2008;57:A574 120.
Cited by
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
The Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup*, Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,290
Standards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
“Insulin infusion protocols with demonstrated safety and efficacy, resulting in low rates of hypoglycemia, are highly recommended (560).”
BackgroundMethodInfluentialStandards of medical care in diabetes—2013
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc13-s011 · Cited by 4,369
Standards of medical care in diabetes 2010
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc10-s011 · Cited by 3,470
Standards of medical care in diabetes—2011
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s011 · Cited by 2,880
Standards of Medical Care in Diabetes—2012
(2012) · Diabetes Care · doi:10.2337/dc12-s011 · Cited by 2,240
“SSI is potentially dangerous in type 1 diabetes (410).”
BackgroundMethodInfluentialKushner, F. G., Hand, M., Smith, S. C., King, S. B., Anderson, J. L., Antman, E. M., Bailey, S. R., Bates, E. R., Blankenship, J. C., Casey, D. E., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.10.015 · Cited by 1,911
Kushner, F. G., Hand, M., Smith, S. C., King, S. B., Anderson, J. L., Antman, E. M., Bailey, S. R., Bates, E. R., Blankenship, J. C., Casey, D. E., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.192663 · Cited by 1,700
Alhazzani, W., Møller, M. H., Arabi, Y. M., Loeb, M., Gong, M. N., Fan, E., Oczkowski, S., Levy, M. M., Derde, L., Dzierba, A., et al. (2020) · Critical Care Medicine · doi:10.1097/ccm.0000000000004363 · Cited by 1,565
Kirkman, M. S., Briscoe, V. J., Clark, N., Florez, H., Haas, L. B., Halter, J. B., Huang, E. S., Korytkowski, M. T., Munshi, M. N., Odegard, P. S., et al. (2012) · Diabetes Care · doi:10.2337/dc12-1801 · Cited by 1,274
Self-citationCallaway, C. W., Donnino, M. W., Fink, E. L., Geocadin, R. G., Golan, E., Kern, K. B., Leary, M., Meurer, W. J., Peberdy, M. A., Thompson, T. M., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000262 · Cited by 1,241
Engelman, D. T., Ben Ali, W., Williams, J. B., Perrault, L. P., Reddy, V. S., Arora, R. C., Roselli, E. E., Khoynezhad, A., Gerdisch, M., Levy, J. H., et al. (2019) · JAMA Surgery · doi:10.1001/jamasurg.2019.1153 · Cited by 1,225
2012 Writing Committee Members, Jneid, H., Anderson, J. L., Wright, R. S., Adams, C. D., Bridges, C. R., Casey, D. E., Ettinger, S. M., Fesmire, F. M., Ganiats, T. G., et al. (2012) · Circulation · doi:10.1161/cir.0b013e318256f1e0 · Cited by 1,090
Global guideline for type 2 diabetes
(2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.10.001 · Cited by 1,064
Anderson, J. L., Adams, C. D., Antman, E. M., Bridges, C. R., Califf, R. M., Casey, D. E., Chavey, W. E., Fesmire, F. M., Hochman, J. S., Levin, T. N., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.01.014 · Cited by 960
Feldheiser, A., Aziz, O., Baldini, G., Cox, B. P. B. W., Fearon, K. C. H., Feldman, L. S., Gan, T. J., Kennedy, R. H., Ljungqvist, O., Lobo, D. N., et al. (2016) · Acta Anaesthesiologica Scandinavica · doi:10.1111/aas.12651 · Cited by 714
Chamberlain, J. J., Rhinehart, A. S., Shaefer, C. F., & Neuman, A. (2016) · Annals of Internal Medicine · doi:10.7326/m15-3016 · Cited by 631
Diabetic emergencies - ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia
Umpierrez, G., & Korytkowski, M. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.15 · Cited by 563
Self-citationHandelsman, Y., Bloomgarden, Z. T., Grunberger, G., Umpierrez, G., Zimmerman, R. S., Bailey, T. S., Blonde, L., Bray, G. A., Cohen, A. J., Dagogo-Jack, S., et al. (2015) · Endocrine Practice · doi:10.4158/ep15672.glsuppl · Cited by 559
Self-citationDiabetes in Older Adults: A Consensus Report
Sue Kirkman, M., Briscoe, V. J., Clark, N., Florez, H., Haas, L. B., Halter, J. B., Huang, E. S., Korytkowski, M. T., Munshi, M. N., Odegard, P. S., et al. (2012) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12035 · Cited by 548
Self-citationBlonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Self-citationJneid, H., Anderson, J. L., Wright, R. S., Adams, C. D., Bridges, C. R., Casey, D. E., Ettinger, S. M., Fesmire, F. M., Ganiats, T. G., Lincoff, A. M., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.06.004 · Cited by 479
16. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s016 · Cited by 440
Perioperative Hyperglycemia Management: An Update
Duggan, E. W., Carlson, K., & Umpierrez, G. E. (2017) · Anesthesiology · doi:10.1097/aln.0000000000001515 · Cited by 402
Self-citationToward Understanding Tight Glycemic Control in the ICU
Marik, P. E., & Preiser, J.-C. (2010) · Chest · doi:10.1378/chest.09-1737 · Cited by 365
Strack, B., DeShazo, J. P., Gennings, C., Olmo, J. L., Ventura, S., Cios, K. J., & Clore, J. N. (2014) · BioMed Research International · doi:10.1155/2014/781670 · Cited by 360
“Recommended standards of care which encourage discontinuation of medications on admission and might prompt changes in medications based on glucose control were only recently adopted [17].”
2011 Writing Group Members, Wright, R. S., Anderson, J. L., Adams, C. D., Bridges, C. R., Casey, D. E., Ettinger, S. M., Fesmire, F. M., Ganiats, T. G., Jneid, H., et al. (2011) · Circulation · doi:10.1161/cir.0b013e31820f2f3e · Cited by 357
Nyenwe, E. A., Jerkins, T. W., Umpierrez, G. E., & Kitabchi, A. E. (2011) · Metabolism · doi:10.1016/j.metabol.2010.09.010 · Cited by 343
“In the critical care setting, continuous IV insulin infusion has been shown to be the most effective method for achieving specific glycemic targets [65,87].”
BackgroundMethodInfluentialSelf-citationWright, R. S., Anderson, J. L., Adams, C. D., Bridges, C. R., Casey, D. E., Ettinger, S. M., Fesmire, F. M., Ganiats, T. G., Jneid, H., Lincoff, A. M., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.02.009 · Cited by 342
Management of diabetes and hyperglycaemia in the hospital
Pasquel, F. J., Lansang, M. C., Dhatariya, K., & Umpierrez, G. E. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30381-8 · Cited by 329
Self-citationKorytkowski, M. T., Muniyappa, R., Antinori-Lent, K., Donihi, A. C., Drincic, A. T., Hirsch, I. B., Luger, A., McDonnell, M. E., Murad, M. H., Nielsen, C., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac278 · Cited by 315
Self-citationNHS Diabetes guideline for the perioperative management of the adult patient with diabetes*
Dhatariya, K., Levy, N., Kilvert, A., Watson, B., Cousins, D., Flanagan, D., Hilton, L., Jairam, C., Leyden, K., Lipp, A., et al. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03582.x · Cited by 312
Joshi, G. P., Chung, F., Vann, M. A., Ahmad, S., Gan, T. J., Goulson, D. T., Merrill, D. G., & Twersky, R. (2010) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3181f9c288 · Cited by 298
Umpierrez, G., Cardona, S., Pasquel, F., Jacobs, S., Peng, L., Unigwe, M., Newton, C. A., Smiley-Byrd, D., Vellanki, P., Halkos, M., et al. (2015) · Diabetes Care · doi:10.2337/dc15-0303 · Cited by 281
Self-citation2007 WRITING COMMITTEE MEMBERS, Anderson, J. L., Adams, C. D., Antman, E. M., Bridges, C. R., Califf, R. M., Casey, D. E., Chavey, W. E., Fesmire, F. M., Hochman, J. S., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31828478ac · Cited by 272
15. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s015 · Cited by 265
Diabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital
Umpierrez, G. E., & Klonoff, D. C. (2018) · Diabetes Care · doi:10.2337/dci18-0002 · Cited by 251
“Current guidelines for the management of hyperglycemia recommend the use of intravenous insulin in the intensive care unit (ICU) and subcutaneous basal or basalbolus insulin regimens in general medicine and surgery settings (4,5).”
BackgroundSelf-citationMunshi, M. N., Florez, H., Huang, E. S., Kalyani, R. R., Mupanomunda, M., Pandya, N., Swift, C. S., Taveira, T. H., & Haas, L. B. (2016) · Diabetes Care · doi:10.2337/dc15-2512 · Cited by 243
Stryker, L. S., Abdel, M. P., Morrey, M. E., Morrow, M. M., Kor, D. J., & Morrey, B. F. (2013) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.l.00494 · Cited by 237
Coronary Artery Disease and Diabetes Mellitus
Aronson, D., & Edelman, E. R. (2014) · Cardiology Clinics · doi:10.1016/j.ccl.2014.04.001 · Cited by 222
Umpierrez, G. E., Smiley, D., Hermayer, K., Khan, A., Olson, D. E., Newton, C., Jacobs, S., Rizzo, M., Peng, L., Reyes, D., et al. (2013) · Diabetes Care · doi:10.2337/dc12-1988 · Cited by 222
Self-citation16. Diabetes Care in the Hospital: Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s016 · Cited by 221
Relationship of Hyperglycemia and Surgical-Site Infection in Orthopaedic Surgery
Richards, J. E., Kauffmann, R. M., Zuckerman, S. L., Obremskey, W. T., & May, A. K. (2012) · The Journal of Bone & Joint Surgery · doi:10.2106/jbjs.k.00193 · Cited by 217
15. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s015 · Cited by 216
Healy, S. J., Black, D., Harris, C., Lorenz, A., & Dungan, K. M. (2013) · Diabetes Care · doi:10.2337/dc13-0108 · Cited by 209
Mendez, C. E., Mok, K.-T., Ata, A., Tanenberg, R. J., Calles-Escandon, J., & Umpierrez, G. E. (2013) · Diabetes Care · doi:10.2337/dc12-2430 · Cited by 209
Self-citationTight Glycemic Control in Critically Ill Children
Agus, M. S. D., Wypij, D., Hirshberg, E. L., Srinivasan, V., Faustino, E. V., Luckett, P. M., Alexander, J. L., Asaro, L. A., Curley, M. A. Q., Steil, G. M., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1612348 · Cited by 204
Continuous monitoring of circadian glycemic patterns in patients receiving prednisolone for COPD
Burt, M. G., Roberts, G. W., Aguilar-Loza, N. R., Frith, P., & Stranks, S. N. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2729 · Cited by 203
“As such, currently, we would not support routine glucose lowering in patients with mild prednisolone-induced hyperglycemia but recommend individualized decision making based on the severity and duration of hyperglycemia, aiming to maintain blood glucose from 72–180 mg/dl (4–10 mmol/liter), in line with general recomme…”
BackgroundInfluential15. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s015 · Cited by 197
Balestrieri, M. L., Rizzo, M. R., Barbieri, M., Paolisso, P., D’Onofrio, N., Giovane, A., Siniscalchi, M., Minicucci, F., Sardu, C., D’Andrea, D., et al. (2015) · Diabetes · doi:10.2337/db14-1149 · Cited by 196
16. Diabetes Care in the Hospital: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s016 · Cited by 195
Phoswa, W. N., & Khaliq, O. P. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/5581570 · Cited by 192
Glycemic Control in Non-Critically Ill Hospitalized Patients: A Systematic Review and Meta-Analysis
Murad, M. H., Coburn, J. A., Coto-Yglesias, F., Dzyubak, S., Hazem, A., Lane, M. A., Prokop, L. J., & Montori, V. M. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2100 · Cited by 192
Wukich, D. K., Crim, B. E., Frykberg, R. G., & Rosario, B. L. (2014) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.l.01302 · Cited by 192
Maradit Kremers, H., Lewallen, L. W., Mabry, T. M., Berry, D. J., Berbari, E. F., & Osmon, D. R. (2015) · The Journal of Arthroplasty · doi:10.1016/j.arth.2014.10.009 · Cited by 191
Islam, M. M., Yang, H.-C., Poly, T. N., Jian, W.-S., & (Jack) Li, Y.-C. (2020) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2020.105320 · Cited by 187
Galindo, R. J., Migdal, A. L., Davis, G. M., Urrutia, M. A., Albury, B., Zambrano, C., Vellanki, P., Pasquel, F. J., Fayfman, M., Peng, L., et al. (2020) · Diabetes Care · doi:10.2337/dc19-2073 · Cited by 181
Self-citationGrunberger, G., Abelseth, J. M., Bailey, T. S., Bode, B. W., Handelsman, Y., Hellman, R., Jovanovič, L., Lane, W. S., Raskin, P., Tamborlane, W. V., et al. (2014) · Endocrine Practice · doi:10.4158/ep14145.ps · Cited by 180
Self-citationEADSG Guidelines: Insulin Therapy in Diabetes
Silver, B., Ramaiya, K., Andrew, S. B., Fredrick, O., Bajaj, S., Kalra, S., Charlotte, B. M., Claudine, K., & Makhoba, A. (2018) · Diabetes Therapy · doi:10.1007/s13300-018-0384-6 · Cited by 179
“Subcutaneous rapid- or short-acting insulin before meals or every 4–6 h may be used in patients not on regular meals or in patients receiving continuous enteral/parenteral nutrition to correct hyperglycemia [148].”
BackgroundInfluential14. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s014 · Cited by 178
Garg, R., Hurwitz, S., Turchin, A., & Trivedi, A. (2013) · Diabetes Care · doi:10.2337/dc12-1296 · Cited by 176
“Current American Diabetes Association guidelines recommend avoiding hypoglycemia in hospitalized patients (15).”
BackgroundScientific Principles and Clinical Implications of Perioperative Glucose Regulation and Control
Akhtar, S., Barash, P. G., & Inzucchi, S. E. (2010) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3181c6be63 · Cited by 176
Self-citationInsulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease
Lo, C., Toyama, T., Wang, Y., Lin, J., Hirakawa, Y., Jun, M., Cass, A., Hawley, C. M., Pilmore, H., Badve, S. V., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011798.pub2 · Cited by 100
Pasquel, F. J., Gianchandani, R., Rubin, D. J., Dungan, K. M., Anzola, I., Gomez, P. C., Peng, L., Hodish, I., Bodnar, T., Wesorick, D., et al. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30402-8 · Cited by 168
Self-citationDiabetes and its negative impact on outcomes in orthopaedic surgery
Wukich, D. K. (2015) · World Journal of Orthopedics · doi:10.5312/wjo.v6.i3.331 · Cited by 168
16. Diabetes Care in the Hospital: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Galindo, R. J., Hilliard, M. E., Johnson, E. L., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s016 · Cited by 167
RSSDI-ESI clinical practice recommendations for the management of type 2 diabetes mellitus 2020
Madhu, S., Chawla, R., Makkar, B., Ghosh, S., Saboo, B., & Kalra, S. (2020) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_225_20 · Cited by 167
Guidelines for Perioperative Management of the Diabetic Patient
Sudhakaran, S., & Surani, S. (2015) · Surgery Research and Practice · doi:10.1155/2015/284063 · Cited by 167
“(v) Establishment of certain glycemic target levels [46, 57], less than 180mg/dL in critical patients and less than 140mg/dL in stable patients [58].”
BackgroundAnees, R. T., Heidler, P., Cavaliere, L. P. L., & Nordin, N. A. (2021) · European Journal of Business Management and Research · doi:10.24018/ejbmr.2021.6.3.849 · Cited by 167
“849 Vol 6 | Issue 3 | May 2021 3 personal health [34]-[36].”
Umpierrez, G. E., Gianchandani, R., Smiley, D., Jacobs, S., Wesorick, D. H., Newton, C., Farrokhi, F., Peng, L., Reyes, D., Lathkar-Pradhan, S., et al. (2013) · Diabetes Care · doi:10.2337/dc13-0277 · Cited by 166
Self-citationA.S.P.E.N. Clinical Guidelines: Nutrition Support of Adult Patients With Hyperglycemia
McMahon, M. M., Nystrom, E., Braunschweig, C., Miles, J., Compher, C., & the American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) Board of Directors (2013) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607112452001 · Cited by 164
Marenzi, G., Cosentino, N., Milazzo, V., Metrio, M. D., Cecere, M., Mosca, S., Rubino, M., Campodonico, J., Moltrasio, M., Marana, I., et al. (2018) · Diabetes Care · doi:10.2337/dc17-1732 · Cited by 163
Zhou, J., & Tan, J. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154216 · Cited by 161
“0 mmol/L for postprandial BG, as the cutoff values [4].”
Management of Inpatient Hyperglycemia and Diabetes in Older Adults
Umpierrez, G. E., & Pasquel, F. J. (2017) · Diabetes Care · doi:10.2337/dc16-0989 · Cited by 159
Self-citationPathways to Quality Inpatient Management of Hyperglycemia and Diabetes: A Call to Action
Draznin, B., Gilden, J., Golden, S. H., Inzucchi, S. E., & for the PRIDE investigators (2013) · Diabetes Care · doi:10.2337/dc12-2508 · Cited by 145
Self-citationInpatient Management of Diabetic Foot Disorders: A Clinical Guide
Wukich, D. K., Armstrong, D. G., Attinger, C. E., Boulton, A. J. M., Burns, P. R., Frykberg, R. G., Hellman, R., Kim, P. J., Lipsky, B. A., Pile, J. C., et al. (2013) · Diabetes Care · doi:10.2337/dc12-2712 · Cited by 140
Self-citationOptimized glycemic control of type 2 diabetes with reinforcement learning: a proof-of-concept trial
Wang, G., Liu, X., Ying, Z., Yang, G., Chen, Z., Liu, Z., Zhang, M., Yan, H., Lu, Y., Gao, Y., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02552-9 · Cited by 156
“The traditional clinical methods of insulin dosage titration were used as the standard clinical methods for comparison, consisting of guidelines 42 and consensus formulas 43,44 for premixed insulin regimen, basal regimen and basal-bolus regimen. https://doi.org/10.1038/s41591-023-02552-9 The…”
MethodInfluentialSpanakis, E. K., Urrutia, A., Galindo, R. J., Vellanki, P., Migdal, A. L., Davis, G., Fayfman, M., Idrees, T., Pasquel, F. J., Coronado, W. Z., et al. (2022) · Diabetes Care · doi:10.2337/dc22-0716 · Cited by 153
Self-citationMifsud, S., Schembri, E. L., & Gruppetta, M. (2018) · British Journal of Hospital Medicine · doi:10.12968/hmed.2018.79.11.634 · Cited by 150
Chase, J. G., Compte, A. J. L., Suhaimi, F. M., Shaw, G. M., Lynn, A. M., Lin, J., Pretty, C. G., Razak, N. N. A., Parente, J. D., Hann, C. E., et al. (2010) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2010.11.006 · Cited by 141
“As a result the fear of hypoglycemia has led to a raising of glycemic target bands [65].”
Insulin Therapy for the Management of Hyperglycemia in Hospitalized Patients
McDonnell, M. E., & Umpierrez, G. E. (2012) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2012.01.001 · Cited by 117
“patients or in patients with severe comorbidities as well as in those in patient-care settings where frequent glucose monitoring or close nursing supervision is not feasible.(18,96,97) In such patients, however, it is prudent to maintain a reasonable degree of glycemic control (BG <11.”
BackgroundMethodSelf-citationHyperglycemia and Perioperative Glucose Management
E. Duncan, A. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212803832236 · Cited by 119
“(Table 1) For example, the American Diabetes Association and the American Association of Clinical Endocrinologists currently recommend starting insulin infusions for critically ill patients with persistent hyperglycemia (glucose greater than 180 mg/dL) and aiming for a target blood glucose range of 140 – 180 mg/dL [71…”
BackgroundGerbaud, E., Darier, R., Montaudon, M., Beauvieux, M.-C., Coffin-Boutreux, C., Coste, P., Douard, H., Ouattara, A., & Catargi, B. (2019) · Diabetes Care · doi:10.2337/dc18-2047 · Cited by 138
Management of Hyperglycemia and Diabetes in Orthopedic Surgery
Akiboye, F., & Rayman, G. A. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0839-6 · Cited by 137
STAR Development and Protocol Comparison
Fisk, L., Compte, A. J. L., Shaw, G. M., Penning, S., Desaive, T., & Chase, J. G. (2012) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2012.2214384 · Cited by 134
“Hence, glycemic control targets have been raised to mitigate these factors and avoid hypoglycemia [17], as a best outcome compromise, despite the physiological and clinical evidence on the negative impact of even moderate hyperglycemia [1], [2], [18].”
BackgroundGoyal, A., Mehta, S. R., Díaz, R., Gerstein, H. C., Afzal, R., Xavier, D., Liu, L., Pais, P., & Yusuf, S. (2009) · Circulation · doi:10.1161/circulationaha.108.837765 · Cited by 130
Diabetic Ketoacidosis in COVID-19: Unique Concerns and Considerations
Palermo, N. E., Sadhu, A. R., & McDonnell, M. E. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa360 · Cited by 123
“Although substantive data on insulin requirements during COVID-19 is not yet published, clinicians have observed higher than usual insulin needs (up to 4 units/kg/day) in critically ill patients with COVID-19 (44)In addition, as described elsewhere,(9) the concomitant use of vasopressors or corticosteroids can signifi…”
BackgroundBoom, D. T., Sechterberger, M. K., Rijkenberg, S., Kreder, S., Bosman, R. J., Wester, J., van Stijn, I., DeVries, J., & van der Voort, P. (2014) · Critical Care · doi:10.1186/preaccept-1799100524125400 · Cited by 115
The effects of elevated hemoglobin A1c in patients with type 2 diabetes mellitus on dental implants
Oates, T. W., Galloway, P. B., Alexander, P. P., Green, A. V., Huynh‐Ba, G., Feine, J., & McMahan, C. A. (2014) · The Journal of the American Dental Association · doi:10.14219/jada.2014.93 · Cited by 127
Iraqi Experts Consensus on the Management of Type 2 Diabetes/Prediabetes in Adults
Abusaib, M., Ahmed, M. J., Nwayyir, H. A., Alidrisi, H. A., Alabbood, M., Albayati, A. H., AL-Ibrahimi, S. M., Al-Kharasani, A. M. R., Alrubaye, H. F., Mahwi, T., et al. (2020) · Clinical Medicine Insights Endocrinology and Diabetes · doi:10.1177/1179551420942232 · Cited by 121
Klonoff, D. C., Messler, J., Umpierrez, G. E., Peng, L., Booth, R., Crowe, J., Garrett, V., McFarland, R., & Pasquel, F. J. (2020) · Diabetes Care · doi:10.2337/dc20-1857 · Cited by 122
Self-citationBellido, V., Suarez, L., Rodriguez, M. G., Sanchez, C., Dieguez, M., Riestra, M., Casal, F., Delgado, E., Menendez, E., & Umpierrez, G. E. (2015) · Diabetes Care · doi:10.2337/dc15-0160 · Cited by 118
Self-citationAnkle and Hindfoot Fusions: Comparison of Outcomes in Patients with and without Diabetes
Myers, T. G., Lowery, N. J., Frykberg, R. G., & Wukich, D. K. (2012) · Foot & Ankle International · doi:10.3113/fai.2012.0020 · Cited by 118
“The American Diabetes Association Consensus statement opines that serum glucose above 140 mg/dl should be treated as inpatients.(21) Consistent with that level we compared patients whose preoperative glucose was greater than 140 mg/dl to those patients with values less than 140.”
BackgroundRichards, J. E., Kauffmann, R. M., Obremskey, W. T., & May, A. K. (2012) · Journal of Orthopaedic Trauma · doi:10.1097/bot.0b013e31825d60e5 · Cited by 117
Parappil, A., Depczynski, B., COLLETT, P., & Marks, G. B. (2010) · Respirology · doi:10.1111/j.1440-1843.2010.01781.x · Cited by 115
Cobaugh, D. J., Maynard, G., Cooper, L., Kienle, P. C., Vigersky, R., Childers, D., Weber, R., Carson, S. L., Mabrey, M. E., Roderman, N., et al. (2013) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp130169 · Cited by 104
“For critically ill patients on insulin therapy, the American Association of Clinical Endocrinologists and the American Diabetes Association (ADA) recommend goal blood glucose concentrations between 140 and 180 mg/dL.(10,12,13) For patients who are not critically ill, ADA recommends maintaining preprandial blood glucos…”
BackgroundYong, P. H., Weinberg, L., Torkamani, N., Churilov, L. P., Robbins, R., Ma, R., Bellomo, R., Lam, Q. T., Burns, J. D., Hart, G. K., et al. (2018) · Diabetes Care · doi:10.2337/dc17-2304 · Cited by 113
Sardu, C., Trotta, M. C., Sasso, F. C., Sacra, C., Carpinella, G., Mauro, C., Minicucci, F., Calabrò, P., Amico, M. D., ́ascenzo, F. D., et al. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01814-7 · Cited by 113
Kushner, F. G., Hand, M. M., Smith, S. C., King, S. B., Anderson, J. L., Antman, E. M., Bailey, S. R., Bates, E., Blankenship, J. C., Casey, D. E., et al. (2009) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.22351 · Cited by 113
Metadata
- Authors
- Moghissi, E. S., Korytkowski, M. T., DiNardo, M., Einhorn, D., Hellman, R., Hirsch, I. B., Inzucchi, S. E., Ismail-Beigi, F., Kirkman, M. S., & Umpierrez, G. E.
- Affiliations
- University of California, Los Angeles (US)
- University of Pittsburgh (US)
- University of California San Diego (US)
- University of Missouri–Kansas City (US)
- University of Washington (US)
- Yale New Haven Hospital (US)
- Department of Medicine, Physiology and Biophysics, Division of Clinical and Molecular Endocrinology, Case Western Reserve University, Cleveland, Ohio;
- American Diabetes Association (US)
- Emory University (US)
- Corresponding author
- Moghissi, Etie S.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-06-01
- Volume
- 32
- Issue
- 6
- Pages
- 1119-1131
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2681039
- OpenAlex
- W2149347361
- Cited by
- 1,444
- References
- 171
- Citations by year
- 2026: 23 · 2025: 48 · 2024: 78 · 2023: 63 · 2022: 66 · 2021: 83 · 2020: 98 · 2019: 67 · 2018: 84 · 2017: 85 · 2016: 101 · 2015: 105 · 2014: 134 · 2013: 89 · 2012: 131
- FWCI
- 76.48
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- inpatient glycemic control, hyperglycemia, stress hyperglycemia, intensive insulin therapy, hypoglycemia, critically ill patients, hospitalized patients, transition to outpatient care, cost-effectiveness, glucose monitoring, clinical outcomes
- MeSH terms
- Blood Glucose, Consensus Statements as Topic, Diabetes Mellitus, Endocrinology, Humans, Hyperglycemia, Inpatients, Societies, Medical
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.